Citation Impact
Citing Papers
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction
1997
Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure
2004
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
1998
The prevention of heart failure in minority communities and discrepancies in health care delivery systems
2004
Relation of Loop Diuretic Dose to Mortality in Advanced Heart Failure
2006
Universal Definition of Myocardial Infarction
2007 Standout
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
2001
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Variations in family physicians’ and cardiologists’ care for patients with heart failure
1999
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Cardiac Failure and Dysrhythmias 6–19 Years After Anthracycline Therapy: A Series of 15 Patients
1995
B-type natriuretic peptide levels: A potential novel “white count” for congestive heart failure
2001
The Spectrum of Dilated Cardiomyopathy: The Johns Hopkins Experience with 1,278 Patients
1999
Risk Factors for Congestive Heart Failure in US Men and Women
2001
Effects of the dipyridamole test on left ventricular function in coronary artery disease
1992
Wound repair and regeneration
2008 StandoutNature
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Valsartan in heart failure patients previously untreated with an ACE inhibitor
1998
Dilated cardiomyopathy
2010
Congestive heart failure hospitalizations and survival in California: Patterns according to race/ethnicity
1999
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Aldosterone and antialdosterone therapy in congestive heart failure
1993
Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors
1997 StandoutNobel
Age and left ventricular ejection fraction identify patients with advanced breast cancer at high risk for development of epirubicin-induced heart failure
1997
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure
1999
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Aldosterone-Induced Inflammation in the Rat Heart
2002
SURGICAL OPTIONS FOR PATIENTS WITH ADVANCED EMPHYSEMA
1997
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
1997
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
1998
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials
2002
Racial Differences in the Outcome of Left Ventricular Dysfunction
1999
Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
1998
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Hormones and Hemodynamics in Heart Failure
1999
Heart failure disease management: a critical review
1999
Complex heart rate variability and serum norepinephrine levels in patients with advanced heart failure
1994
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure
1993
Successes and failures of current treatment of heart failure
1998
G protein‐coupled receptor signalling in in vivo cardiac overload
2001
Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation
1990
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study
2001 Standout
Early Ultrafiltration in Patients With Decompensated Heart Failure and Diuretic Resistance
2005
Ventricular Dilatation and Remodeling After Myocardial Infarction
1994
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study
1998
The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure
2003
Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: A preliminary study
1998
Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure
1999
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Nonparallel changes in global left ventricular chamber volume and muscle mass during the first year after transmural myocardial infarction in humans
1993
Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart Failure
1996
Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function
2003
Comprehensive multidisciplinary programs for the management of patients with congestive heart failure
1999
Inflammation in atherosclerosis
2002 StandoutNature
Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart Disease fn1fn1This study was funded by a grant from SmithKline Beecham; however, the study was initiated, conducted, analyzed and reported by the Australia–New Zealand Heart Failure Research Collaborative Group independently of the sponsor. The Clinical Trials Research Unit is supported by a programme grant from the Health Research Council of New Zealand.
1997
Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor Kinase
1997
Angiotensin‐Converting Enzyme Inhibitor Use in Older Patients with Heart Failure and Renal Dysfunction
1999
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
Direct Inhibition of Type 5 Adenylyl Cyclase Prevents Myocardial Apoptosis without Functional Deterioration
2004
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
1996
Use of the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death
1995
The pathophysiology of acute heart failure—Is it all about fluid accumulation?
2007
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
1999
Diastolic Heart Failure
2004
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)
2005
Atherosclerosis
2000 StandoutNature
Detection of anthracycline-induced cardiotoxicity
1999
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry
1996
A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure
1995 Standout
Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure
1998
Contracted plasma and blood volume in chronic heart failure
2000
Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors
2000
Congestive Heart Failure: Potential Role of Arginine Vasopressin Antagonists in the Therapy of Heart Failure
2002
Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure
2007
Activation of neurohumoral systems following acute myocardial infarction
1991
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Vasopressin receptor antagonists
2006
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography
1991
Race, Quality of Care, and Outcomes of Elderly Patients Hospitalized With Heart Failure
2003
Drugs, Heart Failure and Quality of Life
1999
Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials
1999
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Acute Hemodynamic Effects of Conivaptan, a Dual V 1A and V 2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure
2001
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Chronic Heart Failure in the United States
1998
Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular Dysfunction
1995
Guidelines for clinical use of cardiac radionuclide imaging report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology
1995
In Vivo Ventricular Gene Delivery of a β-Adrenergic Receptor Kinase Inhibitor to the Failing Heart Reverses Cardiac Dysfunction
2001 StandoutNobel
Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity
1983
Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure
1997
Acute Hemodynamic Interaction of Aspirin and Ticlopidine With Enalapril
1998
Gender Differences in Survival in Advanced Heart Failure
1999
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
2000 Standout
Measurement and significance of circulating natriuretic peptides in cardiovascular disease
1998
Congestive heart failure with normal systolic function
1984
Doxorubicin hydrochloride (adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiography
1985
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
2006 StandoutNobel
Modifier genes for hypertrophic cardiomyopathy
2002
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
1979 Standout
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
2003
Plasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin
1998
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure
1997
Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular Dysfunction
1999
Positron Tomography and Nuclear Magnetic Resonance Imaging
1982 StandoutScienceNobel
Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial Hypertrophy
1998 StandoutScienceNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide Cineangiography
1981
Anthracycline cardiotoxicity: Clinical and pathologic outcomes assessed by radionuclide ejection fraction
1980
?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
1995
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast
1985
Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr Mutation
1999
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
1996
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.
1992
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Heart Rate Variability
1996 Standout
Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
1998
RADIONUCLIDE ASSESSMENT OF LEFT AND RIGHT VENTRICULAR PERFORMANCE
1980
The Anthracycline Antineoplastic Drugs
1981 Standout
Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
2002
Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol
2004
Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil
1999
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
1993
In Vivo Inhibition of Elevated Myocardial β-Adrenergic Receptor Kinase Activity in Hybrid Transgenic Mice Restores Normal β-Adrenergic Signaling and Function
1999 StandoutNobel
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
1982
Level of β-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure
2005 StandoutNobel
Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer
2001
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
1994
Brain natriuretic peptide predicts mortality in the elderly.
1997
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
1999
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of David E. Johnstone being referenced
Natural history and patterns of current practice in heart failure
1993
Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction
1994
Thoracoscopic laser bullectomy: A prospective study with three-month results
1996
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of studies of left ventricular dysfunction
1994
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction
1995
Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry
1993
Clinical characteristics of patients in Studies of Left Ventricular Dysfunction (SOLVD)
1992
Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: Validation of the technique and assessment of variability
1979
Neurohumoral variability in left ventricular dysfunction
1995
Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction
1996
Global and regional left ventricular response to bicycle exercise in coronary artery disease
1979
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
1990 Standout
Relation of HFE gene mutations, high iron stores and early onset coronary artery disease.
1998
Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril
2001
Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography
1979